Protocols
3 protocol(s) meet the specified criteria
Drug: COBIMETINIB
Protocol No.TitleStatus
A071601-CIRBPhase II Trial of BRAF/MEK Inhibitors in Papillary CraniopharyngiomasOpen
ML28897PRO/02My Pathway: An Open-Label Phase IIA Study Evaluating Trastuzumab/Pertuzumab, Erlotinib, Vemurafenib/Cobimetinib, and Vismodegib in Patients who have Advanced Solid Tumors with Mutations or Gene Expression Abnormalities Predictive of Response to one of these Agents.Open
NCI-10139-CIRBA Randomized Phase 2 Study of Atezolizumab in Combination with Cobimetinib versus Atezolizumab Monotherapy in Participants with Unresectable CholangiocarcinomaOpen